• “Addicts Use Imodium to Help With Detox. That’s a Terrible Reason for the FDA to Make It Harder to Get” [Mike Riggs, Reason] Expect runs: “Does anyone see the humor/irony here? A diarrhea medicine package that’s hard to open?” [Josh Bloom, ACSH]
• “The Return of Drug Reimportation?” [Roger Pilon, Cato; more thoughts from David R. Henderson]
• California Supreme Court rules research drugmakers legally responsible “for harm caused by defective warnings in labels on generic versions of their products” [T.H. v. Novartis; Bob Egelko, San Francisco Chronicle, Steven Boranian (“awful”), Jim Beck]
• “Abuse-Deterrent Opioids and the Law of Unintended Consequences” [Jeffrey Singer, Cato Policy Analysis]
• Should the FDA approve Metformin for possible anti-aging effects? [Alex Tabarrok]
• “FDA Proposes to Delay Off-Label “Intended Use” Rule” [Stephen McConnell]

Filed under: California, FDA, illegal drugs, opioids, pharmaceuticals